Skip to content

Diiodohydroxyquinoline

GENITO URINARY SYSTEM AND SEX HORMONES

Also known as: diiodohydroxyquin, diiodoquin, diiodoquinol, iodoquinol

FDA approvedATC G01AC01

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Diiodohydroxyquinoline is a drug catalogued in DrugCentral. DrugCentral lists 11 molecular targets, including MAPK1, MAPK14 and ADORA3. Recorded indications include Amebic infection.

  • Molecular targets: MAPK1, MAPK14, ADORA3 and ACE (11 listed in DrugCentral).
  • Indications: Amebic infection.
  • ATC code: G01AC01 (Quinoline derivatives).
  • Molecular formula: C9H5I2NO; molecular weight 396.95 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Amebic infection

Off-label uses (6)

  • Atopic dermatitis
  • Contact dermatitis
  • Eruption of skin
  • Lichen simplex chronicus
  • Pruritus ani
  • Pruritus of genital organs

Contraindications (7)

  • Adrenal cortical hypofunction
  • Atrophoderma
  • Disease of liver
  • Optic neuritis
  • Peripheral nerve disease
  • Peripheral vascular disease
  • Telangiectasia disorder

Mechanism & targets

Molecular targets (11)

TargetGeneActionActivity
Mitogen-activated protein kinase 1MAPK1unknownIC50 6.53
Mitogen-activated protein kinase 14MAPK14unknownIC50 6.44
Adenosine receptor A3ADORA3unknownKi 6.28
Angiotensin-converting enzymeACEunknownIC50 6.04
Tyrosine-protein kinase FynFYNunknownIC50 5.80
Epidermal growth factor receptorEGFRunknownIC50 5.72
Tyrosine-protein kinase LckLCKunknownIC50 5.61
Beta-lactamase NDM-1blaNDM-1unknownIC50 5.60
Mitogen-activated protein kinase 3MAPK3unknownIC50 5.28
Catechol O-methyltransferaseComtunknownIC50 5.25
Receptor tyrosine-protein kinase erbB-2ERBB2unknownIC50 5.07

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
—FDA——

ATC classification

ATC codeTherapeutic hierarchy
G01AC01GENITO URINARY SYSTEM AND SEX HORMONES › GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS › ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS › Quinoline derivatives

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Diiodohydroxyquinoline is on its molecule page.

Molecular formulaC9H5I2NO
Molecular weight396.95 g/mol
CAS number83-73-8
InChIKeyUXZFQZANDVDGMM-UHFFFAOYSA-N
PubChem CID3728
OC1=C2N=CC=CC2=C(I)C=C1I

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Diiodohydroxyquinoline used for?

DrugCentral lists the following indications for Diiodohydroxyquinoline: Amebic infection.

How does Diiodohydroxyquinoline work?

Its molecular targets in DrugCentral include MAPK1, MAPK14, ADORA3 and ACE.

What is the chemical formula of Diiodohydroxyquinoline?

Diiodohydroxyquinoline has the molecular formula C9H5I2NO and a molecular weight of 396.95 g/mol.

Browse: all drugs starting with D · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
AgencyFDA
Targets11
Indications1
FormulaC9H5I2NO
DrugCentral ID1457
Interactive profile